2018 - Fellow, National Academy of Inventors
Her primary areas of investigation include Muscular dystrophy, Dystrophin, Genetics, Molecular biology and Sarcoglycan. Her Muscular dystrophy study frequently draws connections to adjacent fields such as Limb-girdle muscular dystrophy. Her research in Dystrophin tackles topics such as Cell biology which are related to areas like Biochemistry.
Elizabeth M. McNally frequently studies issues relating to Cardiomyopathy and Genetics. Elizabeth M. McNally combines subjects such as Lamin, Gene expression, Gene, Virology and Emerin with her study of Molecular biology. Her research integrates issues of Sarcoglycans and Dystroglycan in her study of Sarcoglycan.
The scientist’s investigation covers issues in Muscular dystrophy, Internal medicine, Cell biology, Genetics and Cardiomyopathy. Her Muscular dystrophy research integrates issues from Limb-girdle muscular dystrophy and Duchenne muscular dystrophy. Her Internal medicine study combines topics in areas such as Endocrinology and Cardiology.
Within one scientific family, Elizabeth M. McNally focuses on topics pertaining to Skeletal muscle under Cell biology, and may sometimes address concerns connected to Cardiac muscle. Her Cardiomyopathy study integrates concerns from other disciplines, such as Genetic heterogeneity, Gene mutation, Dilated cardiomyopathy and Genetic testing. Her study looks at the relationship between Dystrophin and topics such as Molecular biology, which overlap with Myosin and Lamin.
Her primary scientific interests are in Internal medicine, Cardiomyopathy, Gene, Heart failure and Genetics. Her Internal medicine research includes elements of Endocrinology and Cardiology. In her research on the topic of Cardiomyopathy, Regulatory sequence and Human heart is strongly related with Enhancer.
Elizabeth M. McNally works mostly in the field of Heart failure, limiting it down to concerns involving Intensive care medicine and, occasionally, Clinical trial, Disease, Duchenne muscular dystrophy, Muscular dystrophy and Genetic testing. She has researched Muscular dystrophy in several fields, including Point mutation, Deflazacort, Prednisone, Skeletal muscle and Myocyte. Her study in Genetics focuses on Phenotype, Genetic variation, Gene expression and Promoter.
Muscular dystrophy, Internal medicine, Cell biology, Dystrophin and Duchenne muscular dystrophy are her primary areas of study. Her work carried out in the field of Muscular dystrophy brings together such families of science as MBNL1, Cellular differentiation, Trinucleotide repeat expansion, Cardiac function curve and Myogenesis. Elizabeth M. McNally works mostly in the field of Internal medicine, limiting it down to topics relating to Cardiology and, in certain cases, Desmoplakin and Intermediate filament.
Her biological study spans a wide range of topics, including Exon skipping, Lamin, Chromosome 3 and Exon. Her Dystrophin research incorporates themes from Myocyte, Actin cytoskeleton and Myostatin. Her Duchenne muscular dystrophy study incorporates themes from Endocrinology, Glucocorticoid and Surrogate endpoint.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses.
David L. Boone;Emre E. Turer;Eric G. Lee;Regina Celeste Ahmad.
Nature Immunology (2004)
Myosin subfragment-1 is sufficient to move actin filaments in vitro.
Yoko Yano Toyoshima;Stephen J. Kron;Elizabeth M. McNally;Kenneth R. Niebling.
Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy
Satoru Noguchi;Elizabeth M. McNally;Kamel Ben Othmane;Yasuko Hagiwara.
The Dystrophin Glycoprotein Complex: Signaling Strength and Integrity for the Sarcolemma
Karen A. Lapidos;Rahul Kakkar;Elizabeth M. McNally.
Circulation Research (2004)
β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
Carsten G. Bönnemann;Raju Modi;Satoru Noguchi;Yuji Mizuno.
Nature Genetics (1995)
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms
Elizabeth M. McNally;Luisa Mestroni.
Circulation Research (2017)
Genetic mutations and mechanisms in dilated cardiomyopathy
Elizabeth M. McNally;Jessica R. Golbus;Megan J. Puckelwartz.
Journal of Clinical Investigation (2013)
Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein
Terri G. Thompson;Yiu Mo Chan;Andrew A. Hack;Melissa Brosius.
Journal of Cell Biology (2000)
γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin
Andrew A. Hack;Chantal T. Ly;Fang Jiang;Cynthia J. Clendenin.
Journal of Cell Biology (1998)
Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.
Gregory Q. Wallace;Elizabeth M. McNally.
Annual Review of Physiology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: